Skip Navigation

Radiotherapy for age-related macular degeneration

Guidance issued Guidance issued
 
IP Guidance Number: IPG49
 
Summary:

The National Institute for Health and Clinical Excellence (NICE) has issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on radiotherapy for age-related macular degeneration.

Description:

Age-related macular degeneration is the commonest cause of irreversible blindness in developed countries. Radiotherapy can be used to destroy new vessels in the wet form of maacular degeneration. It is usually given as a day treatment. The beam of radiotherapy is angled to avoid damage to the optic nerve and structures in the other eye.

Arrangements:

Research Only

Topic Area:

Eye
Surgical procedures

Specialty:

Geriatric medicine
Medical opthalmology

Specialist advice has
been sought from:
Royal College of Ophthalmologists
Date notified to NICE: 01 April 2002
Guidance Publication Date: 24 March 2004
Contact Details:
Project Manager
(for general enquiries or comments)
Ben Doak
ip@nice.org.uk
Contact Address:

Interventional Procedures Programme
National Institute for Health and Clinical Excellence
MidCity Place
71 High Holborn
London
WC1V 6NA


Links:

Search NICE guidance


Advanced guidance search

Related guidance

Click the links below to see guidance on similar topics